Literature DB >> 25880955

Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs.

Christine U Oramasionwu1, Terence L Johnson, William A Zule, Jessica Carda-Auten, Carol E Golin.   

Abstract

Ongoing injection drug use contributes to the HIV and HCV epidemics in people who inject drugs. In many places, pharmacies are the primary source of sterile syringes for people who inject drugs; thus, pharmacies provide a viable public health service that reduces blood-borne disease transmission. Replacing the supply of high dead space syringes with low dead space syringes could have far-reaching benefits that include further prevention of disease transmission in people who inject drugs and reductions in dosing inaccuracies, medication errors, and medication waste in patients who use syringes. We explored using pharmacies in a structural intervention to increase the uptake of low dead space syringes as part of a comprehensive strategy to reverse these epidemics.

Entities:  

Mesh:

Year:  2015        PMID: 25880955      PMCID: PMC4431115          DOI: 10.2105/AJPH.2015.302581

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  36 in total

1.  Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices.

Authors:  C R Harbke; D G Fisher; H H Cagle; B N Trubatch; A M Fenaughty; M E Johnson
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

3.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

4.  Errors in insulin doses due to the design of insulin syringes.

Authors:  F J Shainfeld
Journal:  Pediatrics       Date:  1975-08       Impact factor: 7.124

5.  Insulin syringe dead-space and diabetic control.

Authors:  N P Mann; D I Johnston
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

Review 6.  Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Authors:  Rositsa B Dimova; Marija Zeremski; Ira M Jacobson; Holly Hagan; Don C Des Jarlais; Andrew H Talal
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

7.  Syringe type and drug injector risk for HIV infection: a case study in Texas.

Authors:  William A Zule; David P Desmond; James Alan Neff
Journal:  Soc Sci Med       Date:  2002-10       Impact factor: 4.634

8.  Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.

Authors:  Yuko Mizuno; David W Purcell; Amy R Knowlton; James D Wilkinson; Marc N Gourevitch; Kelly R Knight
Journal:  AIDS Behav       Date:  2015-04

9.  Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.

Authors:  Maxine M Denniston; Ruth B Jiles; Jan Drobeniuc; R Monina Klevens; John W Ward; Geraldine M McQuillan; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries.

Authors:  Theodore M Hammett; Son Phan; Julia Gaggin; Patricia Case; Nicholas Zaller; Alexandra Lutnick; Alex H Kral; Ekaterina V Fedorova; Robert Heimer; Will Small; Robin Pollini; Leo Beletsky; Carl Latkin; Don C Des Jarlais
Journal:  BMC Health Serv Res       Date:  2014-06-17       Impact factor: 2.655

View more
  4 in total

1.  Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.

Authors:  William A Zule; Christine Oramasionwu; Donna Evon; Sayaka Hino; Irene A Doherty; Georgiy V Bobashev; Wendee M Wechsberg
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-10       Impact factor: 3.829

2.  Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.

Authors:  Adam Trickey; Margaret T May; Vivian Hope; Zoe Ward; Monica Desai; Ellen Heinsbroek; Matthew Hickman; Peter Vickerman
Journal:  Drug Alcohol Depend       Date:  2018-09-15       Impact factor: 4.492

3.  Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States.

Authors:  Charitha Gowda; Vincent Lo Re
Journal:  Curr Hepatol Rep       Date:  2018-03-24

4.  Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico.

Authors:  Ian Duncan; Patrick Habecker; Roberto Abadie; Ric Curtis; Bilal Khan; Kirk Dombrowski
Journal:  Harm Reduct J       Date:  2017-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.